Prevalence and burden of chronic migraine in adolescents: Results of the chronic daily headache in adolescents study (C-dAS)

Richard B. Lipton, Aubrey Manack, Judith A. Ricci, Elsbeth Chee, Catherine C. Turkel, Paul Winner

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Objective.- To estimate the prevalence of chronic migraine (CM) among adolescents and to describe the epidemiologic profile, headache characteristics, disability, and healthcare utilization of adolescents with CM in the USA. Background.- Chronic daily headache (CDH) and CM occur in children and adolescents, but are poorly understood in these populations because their presentation is different from that in adults. It may be difficult to assign a definitive diagnosis to young people suffering from CDH because symptoms may fail to meet the criteria for one of the CDH subtypes. Methods.- A large sample of households with at least one resident aged 12 to 19 years was selected in balance with the US Census. Data were collected in 3 phases: (1) mailed questionnaire; (2) telephone interview; and (3) 30-day interactive voice response system diary. CM prevalence was estimated by adapting the second edition of the International Classification of Headache Disorders criteria for CM to include pediatric migraine diagnostic criteria. The population was stratified for medication overuse. Medication overuse was defined as 15 or more days per month of acute medication use. Included in the study were measures of headache characteristics, headache impact (Headache Impact Test), disability (Pediatric Migraine Disability Assessment), and healthcare and medication use. Data are reported on subjects 12 to 17 years of age only. Results.- The US adolescent (12-17 years) prevalence rate for CM was 0.79% (0.00-1.70) excluding those with medication overuse and 1.75% (0.62-2.89) when adolescents with medication overuse were included. The majority of adolescents with CM had Headache Impact Test scores greater than or equal to 60, indicating severe headache impact, and mean Pediatric Migraine Disability Assessment scores greater than 17, indicating severe headache and disability. The majority of adolescents with CM (approximately 60%) had not visited a healthcare provider in the previous year and less than one in 5 reported taking medications to prevent headaches during the last month. Conclusions.- Results suggest that CM occurs less frequently in adolescents than adults, but like adults, adolescents are severely burdened by the disorder. Data support an unmet medical need; however, the development of optimal criteria for diagnosing adolescents with CM is critical to fully understanding how medical needs can be met within this complex population.

Original languageEnglish (US)
Pages (from-to)693-706
Number of pages14
JournalHeadache
Volume51
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Headache Disorders
Migraine Disorders
Headache
Pediatrics
Population
Delivery of Health Care
Censuses
Health Personnel

Keywords

  • adolescent
  • burden of illness
  • chronic daily headache
  • chronic migraine
  • classification
  • epidemiology

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Prevalence and burden of chronic migraine in adolescents : Results of the chronic daily headache in adolescents study (C-dAS). / Lipton, Richard B.; Manack, Aubrey; Ricci, Judith A.; Chee, Elsbeth; Turkel, Catherine C.; Winner, Paul.

In: Headache, Vol. 51, No. 5, 05.2011, p. 693-706.

Research output: Contribution to journalArticle

Lipton, Richard B. ; Manack, Aubrey ; Ricci, Judith A. ; Chee, Elsbeth ; Turkel, Catherine C. ; Winner, Paul. / Prevalence and burden of chronic migraine in adolescents : Results of the chronic daily headache in adolescents study (C-dAS). In: Headache. 2011 ; Vol. 51, No. 5. pp. 693-706.
@article{308aec62cbc94feca4aa32567f1fb94f,
title = "Prevalence and burden of chronic migraine in adolescents: Results of the chronic daily headache in adolescents study (C-dAS)",
abstract = "Objective.- To estimate the prevalence of chronic migraine (CM) among adolescents and to describe the epidemiologic profile, headache characteristics, disability, and healthcare utilization of adolescents with CM in the USA. Background.- Chronic daily headache (CDH) and CM occur in children and adolescents, but are poorly understood in these populations because their presentation is different from that in adults. It may be difficult to assign a definitive diagnosis to young people suffering from CDH because symptoms may fail to meet the criteria for one of the CDH subtypes. Methods.- A large sample of households with at least one resident aged 12 to 19 years was selected in balance with the US Census. Data were collected in 3 phases: (1) mailed questionnaire; (2) telephone interview; and (3) 30-day interactive voice response system diary. CM prevalence was estimated by adapting the second edition of the International Classification of Headache Disorders criteria for CM to include pediatric migraine diagnostic criteria. The population was stratified for medication overuse. Medication overuse was defined as 15 or more days per month of acute medication use. Included in the study were measures of headache characteristics, headache impact (Headache Impact Test), disability (Pediatric Migraine Disability Assessment), and healthcare and medication use. Data are reported on subjects 12 to 17 years of age only. Results.- The US adolescent (12-17 years) prevalence rate for CM was 0.79{\%} (0.00-1.70) excluding those with medication overuse and 1.75{\%} (0.62-2.89) when adolescents with medication overuse were included. The majority of adolescents with CM had Headache Impact Test scores greater than or equal to 60, indicating severe headache impact, and mean Pediatric Migraine Disability Assessment scores greater than 17, indicating severe headache and disability. The majority of adolescents with CM (approximately 60{\%}) had not visited a healthcare provider in the previous year and less than one in 5 reported taking medications to prevent headaches during the last month. Conclusions.- Results suggest that CM occurs less frequently in adolescents than adults, but like adults, adolescents are severely burdened by the disorder. Data support an unmet medical need; however, the development of optimal criteria for diagnosing adolescents with CM is critical to fully understanding how medical needs can be met within this complex population.",
keywords = "adolescent, burden of illness, chronic daily headache, chronic migraine, classification, epidemiology",
author = "Lipton, {Richard B.} and Aubrey Manack and Ricci, {Judith A.} and Elsbeth Chee and Turkel, {Catherine C.} and Paul Winner",
year = "2011",
month = "5",
doi = "10.1111/j.1526-4610.2011.01885.x",
language = "English (US)",
volume = "51",
pages = "693--706",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Prevalence and burden of chronic migraine in adolescents

T2 - Results of the chronic daily headache in adolescents study (C-dAS)

AU - Lipton, Richard B.

AU - Manack, Aubrey

AU - Ricci, Judith A.

AU - Chee, Elsbeth

AU - Turkel, Catherine C.

AU - Winner, Paul

PY - 2011/5

Y1 - 2011/5

N2 - Objective.- To estimate the prevalence of chronic migraine (CM) among adolescents and to describe the epidemiologic profile, headache characteristics, disability, and healthcare utilization of adolescents with CM in the USA. Background.- Chronic daily headache (CDH) and CM occur in children and adolescents, but are poorly understood in these populations because their presentation is different from that in adults. It may be difficult to assign a definitive diagnosis to young people suffering from CDH because symptoms may fail to meet the criteria for one of the CDH subtypes. Methods.- A large sample of households with at least one resident aged 12 to 19 years was selected in balance with the US Census. Data were collected in 3 phases: (1) mailed questionnaire; (2) telephone interview; and (3) 30-day interactive voice response system diary. CM prevalence was estimated by adapting the second edition of the International Classification of Headache Disorders criteria for CM to include pediatric migraine diagnostic criteria. The population was stratified for medication overuse. Medication overuse was defined as 15 or more days per month of acute medication use. Included in the study were measures of headache characteristics, headache impact (Headache Impact Test), disability (Pediatric Migraine Disability Assessment), and healthcare and medication use. Data are reported on subjects 12 to 17 years of age only. Results.- The US adolescent (12-17 years) prevalence rate for CM was 0.79% (0.00-1.70) excluding those with medication overuse and 1.75% (0.62-2.89) when adolescents with medication overuse were included. The majority of adolescents with CM had Headache Impact Test scores greater than or equal to 60, indicating severe headache impact, and mean Pediatric Migraine Disability Assessment scores greater than 17, indicating severe headache and disability. The majority of adolescents with CM (approximately 60%) had not visited a healthcare provider in the previous year and less than one in 5 reported taking medications to prevent headaches during the last month. Conclusions.- Results suggest that CM occurs less frequently in adolescents than adults, but like adults, adolescents are severely burdened by the disorder. Data support an unmet medical need; however, the development of optimal criteria for diagnosing adolescents with CM is critical to fully understanding how medical needs can be met within this complex population.

AB - Objective.- To estimate the prevalence of chronic migraine (CM) among adolescents and to describe the epidemiologic profile, headache characteristics, disability, and healthcare utilization of adolescents with CM in the USA. Background.- Chronic daily headache (CDH) and CM occur in children and adolescents, but are poorly understood in these populations because their presentation is different from that in adults. It may be difficult to assign a definitive diagnosis to young people suffering from CDH because symptoms may fail to meet the criteria for one of the CDH subtypes. Methods.- A large sample of households with at least one resident aged 12 to 19 years was selected in balance with the US Census. Data were collected in 3 phases: (1) mailed questionnaire; (2) telephone interview; and (3) 30-day interactive voice response system diary. CM prevalence was estimated by adapting the second edition of the International Classification of Headache Disorders criteria for CM to include pediatric migraine diagnostic criteria. The population was stratified for medication overuse. Medication overuse was defined as 15 or more days per month of acute medication use. Included in the study were measures of headache characteristics, headache impact (Headache Impact Test), disability (Pediatric Migraine Disability Assessment), and healthcare and medication use. Data are reported on subjects 12 to 17 years of age only. Results.- The US adolescent (12-17 years) prevalence rate for CM was 0.79% (0.00-1.70) excluding those with medication overuse and 1.75% (0.62-2.89) when adolescents with medication overuse were included. The majority of adolescents with CM had Headache Impact Test scores greater than or equal to 60, indicating severe headache impact, and mean Pediatric Migraine Disability Assessment scores greater than 17, indicating severe headache and disability. The majority of adolescents with CM (approximately 60%) had not visited a healthcare provider in the previous year and less than one in 5 reported taking medications to prevent headaches during the last month. Conclusions.- Results suggest that CM occurs less frequently in adolescents than adults, but like adults, adolescents are severely burdened by the disorder. Data support an unmet medical need; however, the development of optimal criteria for diagnosing adolescents with CM is critical to fully understanding how medical needs can be met within this complex population.

KW - adolescent

KW - burden of illness

KW - chronic daily headache

KW - chronic migraine

KW - classification

KW - epidemiology

UR - http://www.scopus.com/inward/record.url?scp=79955371162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955371162&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2011.01885.x

DO - 10.1111/j.1526-4610.2011.01885.x

M3 - Article

C2 - 21521206

AN - SCOPUS:79955371162

VL - 51

SP - 693

EP - 706

JO - Headache

JF - Headache

SN - 0017-8748

IS - 5

ER -